通过VBX1000抑制甲素K可以缓解犬类牙周炎
Jerzy Gawor1, Daria Ziemann Gawor1, Isabelle Druet2
1Klinika Weterynaryjna Arka, Krakow, Poland.
Frontiers in veterinary science
|December 8, 2025
概括
一种新型的甲素K抑制剂VBX1000通过减少骨吸收和改善临床措施,有效治疗狗的牙周病. 这表明VBX1000是治疗犬牙周病的一种有前途的治疗方法.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 药理学 药理学是指药理学的学科.
- 牙周病学 牙周病学
背景情况:
- 牙周病是狗的常见疾病,其特点是支持结构的炎症和破坏.
- 甲素K在骨再吸收中起着至关重要的作用,使其成为牙周病的潜在治疗点.
研究的目的:
- 评估新型甲素K抑制剂VBX1000在患有牙周病的客户拥有的狗中的疗效和安全性.
- 评估VBX1000对骨再吸收标志物和临床牙周指标的影响.
主要方法:
- 一项涉及20只患有第2或第3阶段牙周病的狗的开放性研究.
- 狗在60天内口服VBX1000 (25或50毫克/公斤),然后在30天内服用50毫克/公斤.
- 评估了血CTX1,临床附着损失 (CAL),牙周探测深度 (PPD),探测出血 (BPI),牙放射 (DR) 和圆束计算断层扫描 (CBCT).
主要成果:
- 在整个治疗期间,VBX1000的耐受性很好.
- 观察到血CTX1水平 (骨再吸收的标志物) 的显著降低.
- 在DR上注意到膜骨缺陷的宽度,深度和高度的减少,并通过CBCT证实.
- 在治疗期间结束时,CAL和PPD的显著减少得到了实现.
结论:
- VBX1000在治疗狗的轻度至中度牙周病方面表现出有效性.
- 通过VBX1000抑制甲素K代表了对狗牙周病的潜在新疗法策略.
- 建议通过随机,双盲,安慰剂对照试验进行进一步的调查,以确认VBX1000的潜力.
更多相关视频
06:06Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
3.0K
06:14Induction of Periodontitis via a Combination of Ligature and Lipopolysaccharide Injection in a Rat Model
Published on: February 17, 2023
5.0K
相关概念视频
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...